Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
0.9959
-0.0091 (-0.91%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Lisata Therapeutics Market Cap
Lisata Therapeutics has a market cap or net worth of $8.97 million as of October 23, 2026. It is the 42,046th most valuable company in the world and the 5,657th biggest in the United States. Its market cap has decreased by 56.44% in one year.
Market Cap
8.97M
Enterprise Value
-1.47M
1-Year Change
-56.44%
Global Rank
Country Rank
#5,657 United States
Category
ChartMarket Cap Chart
Since August 9, 2007, Lisata Therapeutics's market cap has decreased from $11.90M to $8.97M, a decrease of -24.59%. That is a compound annual growth rate of -1.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 8.97M | -45.28% |
| Dec 31, 2025 | 16.40M | -34.40% |
| Dec 31, 2024 | 25.00M | 12.61% |
| Dec 29, 2023 | 22.20M | 11.56% |
| Dec 30, 2022 | 19.90M | -60.44% |
| Dec 31, 2021 | 50.30M | 81.59% |
| Dec 31, 2020 | 27.70M | 6.13% |
| Dec 31, 2019 | 26.10M | -25.43% |
| Dec 31, 2018 | 35.00M | 5.42% |
| Dec 29, 2017 | 33.20M | 43.72% |
| Dec 30, 2016 | 23.10M | -61.37% |
| Dec 31, 2015 | 59.80M | -55.61% |
| Dec 31, 2014 | 134.70M | -27.23% |
| Dec 31, 2013 | 185.10M | 93.62% |
| Dec 31, 2012 | 95.60M | 74.77% |
| Dec 30, 2011 | 54.70M | -32.64% |
| Dec 31, 2010 | 81.20M | 43.46% |
| Dec 31, 2009 | 56.60M | 1,564.71% |
| Dec 31, 2008 | 3.40M | -46.03% |
| Dec 31, 2007 | 6.30M | -47.06% |
| Aug 9, 2007 | 11.90M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioVie | 9.43M |
| Palatin Technologies | 9.37M |
| Ensysce Biosciences | 9.34M |
| MetaVia | 9.29M |
| Immuron | 9.04M |
| Theriva Biologics | 8.97M |
| CalciMedica | 8.47M |
| Tempest Therapeutics | 8.44M |